HMTM
LIVE
Serial Number
79345433
Owner
TauRx Therapeutics LtdAttorney
Thad ChaloemtiaranaFiling Date
May 12, 2022
HMTM Trademark
Serial Number: 79345433 • Registration: 7245025
HMTM is a trademark filed by
TauRx Therapeutics Ltd
on May 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard
200 S. Wacker Dr.
Suite 2900
Chicago
IL 60606
Trademark Details
Filing Date
May 12, 2022
Registration Date
December 19, 2023
Published for Opposition
October 3, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 2, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 2, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 19, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 19, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Oct 4, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 13, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2023 TROA
REFUSAL PROCESSED BY IB
May 24, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 21, 2022 REPR
